According to the CDC, as of August 2023, 40.3 percent of U.S. adults—some 100 million people—met the clinical definition for obesity. But this same estimate, which is based on National Health ...

Oct. 30, 2024 — Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related ...

This year's theme, 'Empowering Person-Centered Diabetes Care and Innovation', aligns with the International Diabetes ...

New data released by the Centers for Disease Control and Prevention (CDC) has provided insight into the prevalence of obesity across the United States. The figures, initially from the 2023 Adult ...

The theme underpins International Diabetes Federation's commitment ... Type 2 diabetes is due to insulin resistance and ...

From this metric, your physician can diagnose whether you are under or average weight, or whether you have obesity. The thing is: BMI is a metric that was not designed to diagnose someone with a ...

Radella Pharmaceuticals has reported topline outcomes from a Phase Ia trial that assessed an investigational therapy for ...

Viking Therapeutics has announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

World Diabetes Day (WDD) will be observed globally on Thursday to raise awareness about diabetes, a chronic condition ...

News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity to their astronomical pricing, drug shortages, compounding disputes ...